Cassandra Pardini, PharmD

Contributing Writer

Cassandra Pardini is a freelance writer and registered pharmacist with a diverse background in drug therapy, scientific research, and the drug discovery and developmental process. She obtained her Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences University, Master of Science degree in chemistry and chemical biology from Northeastern University, and Bachelor of Science degree in chemistry from Boston College. She currently lives in Rhode Island with her husband and 3 children.

All articles by Cassandra Pardini, PharmD

General Pain

NSAID Use Among US Adults With Cardiovascular Disease Examined

Cassandra Pardini, PharmD

December 17, 2020

Trends in NSAID use among patients with cardiovascular disease show that use has declined over time but in a subset of patients it remains routine.

Musculoskeletal Pain

High-Quality Evidence Lacking for Most Fibromyalgia Therapies

Cassandra Pardini, PharmD

November 17, 2020

The majority of treatment options for fibromyalgia are not supported by high-quality evidence.

Acute Pain

Study Finds Possible Link Between Labor Epidural Analgesia and ASD Risk

Cassandra Pardini, PharmD

October 16, 2020

Maternal exposure to labor epidural analgesia (LEA) may be associated with an increased risk of autism spectrum disorders in offspring.

Migraine & Headache

Timolol Ophthalmic Drops Evaluated for Acute Migraine

Cassandra Pardini, PharmD

October 8, 2020

Timolol maleate ophthalmic solution was found to be effective in managing acute migraine pain.

Case Studies

Antidepressant, NSAID Identified as Culprits in SIADH Case

Cassandra Pardini, PharmD

September 24, 2020

The patient noted that she was initiated on naproxen by her primary care physician 2 weeks prior to her presentation.

General Pain

Supplements With Undeclared Active Ingredients Pose Substantial Health Risk

Cassandra Pardini, PharmD

June 30, 2020

A recent Morbidity and Mortality Weekly Report highlights the risks associated with use of OTC products containing undeclared prescription ingredients as well as the importance of collaboration between various health departments and systems to ensure a prompt response to an outbreak.

General Pain

Evidence Supporting Dietary Supplement Use for COVID-19 Lacking

Cassandra Pardini, PharmD

May 29, 2020

There is a lack of evidence supporting the use of dietary supplements for the prevention or treatment of COVID-19, despite what recent news or social media platforms have asserted,

General Pain

Evidence Supporting Use of Compounded Topical Pain Creams Limited

Cassandra Pardini, PharmD

May 26, 2020

“In context of the recent rise in supply and demand of compounded preparations, lack of evidence regarding systemic absorption of ingredients used in compounded topical pain creams gives rise to a substantial public health concern,” the authors concluded.

General Pain

Guidance Issued on Managing Pain During Public Health Crises

Cassandra Pardini, PharmD

April 14, 2020

In order to provide national guidance addressing issues surrounding pain management practices, an expert panel was convened to provide a framework for pain practitioners and institutions.

Migraine & Headache

Meloxicam/Rizatriptan Combination Superior to Placebo in Migraine Trial

Cassandra Pardini, PharmD

April 9, 2020

Treatment with AXS-07, an investigational therapy being developed by Axsome Therapeutics, substantially reduced migraine pain and significantly prevented the progression of migraine pain intensity, according to results of the phase 3 INTERCEPT trial.

Next post in Migraine & Headache